Offrez un coup d’avance à vos collaborateurs

Santé

Le grand chamboule-tout d’Olivier Laureau à la tête de Servier

En plein procès en appel sur le scandale du Mediator, le groupe pharmaceutique bouleverse son organisation et met son management sous pression.

French pharmaceutical firm Servier's current president Olivier Laureau speaks to the press 
as he arrives on September 23, 2019 in Paris' courthouse before the start of the trial of France's medicines watchdog and Servier on fraud and negligence charges linked to the deaths of hundreds of people who were prescribed a diabetes pill for weight loss despite safety concerns. - At least 500 people are thought to have died of heart valve problems in France after taking the drug Mediator. The criminal trial against Servier, nine subsidiaries, and the ANSM medicines watchdog, known at the time as Afssaps, is expected to last six months. It will focus on 91 victims, four of them deceased, for whom lawyers believe a link can be shown between their illness and Mediator. (Photo by Bertrand GUAY / AFP)
French pharmaceutical firm Servier's current president Olivier Laureau speaks to the press as he arrives on September 23, 2019 in Paris' courthouse before the start of the trial of France's medicines watchdog and Servier on fraud and negligence charges linked to the deaths of hundreds of people who were prescribed a diabetes pill for weight loss despite safety concerns. - At least 500 people are thought to have died of heart valve problems in France after taking the drug Mediator. The criminal trial against Servier, nine subsidiaries, and the ANSM medicines watchdog, known at the time as Afssaps, is expected to last six months. It will focus on 91 victims, four of them deceased, for whom lawyers believe a link can be shown between their illness and Mediator. (Photo by Bertrand GUAY / AFP) BERTRAND GUAY / AFP

La réorganisation interne engagée par Servier pour atteindre ses objectifs 2030 s’accélère. Au moment où le procès en appel sur le scandale du Mediator place le groupe sous le feu des projecteurs, le top management est en plein chambardement. Depuis trois mois, départs et nominations se succèdent à un rythme soutenu, préfigurant la nouvelle arborescence qui doit être annoncée au printemps. L’Informé vous en dévoile les détails.